Understanding how slow-acting drugs work in the body

Mechanism of Slow Onset Enzyme Inhibition and Translation to Time-Dependent Drug Activity

NIH-funded research State University New York Stony Brook · NIH-10909811

This study is looking at how the timing of when antibiotics interact with their targets can make them work better against infections, helping to create more effective treatments for patients.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionState University New York Stony Brook NIH-funded
Lab location1 site (Stony Brook, United States)
Project IDNIH-10909811 on NIH RePORTER

What this research studies

This research investigates how the timing of drug interactions with their targets affects their effectiveness in treating infections. It focuses on understanding the molecular mechanisms behind slow-onset enzyme inhibition, particularly for antibacterial drugs. By studying how drugs bind and release from their targets over time, the research aims to improve predictions of drug efficacy in real-world conditions. The approach combines structural biology, computational modeling, and enzyme kinetics to develop better drug candidates.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals suffering from bacterial infections who may benefit from improved antibiotic therapies.

Not a fit: Patients with viral infections or those who do not respond to antibiotic treatments may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective antibiotics that work better in patients by improving how we understand drug action over time.

How similar studies have performed: Previous research has shown promise in understanding drug-target interactions, but this specific approach to slow-onset enzyme inhibition is relatively novel.

Where this research is happening

Stony Brook, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.